Webcast and conference call to be held on Monday, June 30th at 4:30 pm ET, dial in information below NEWARK, CA / ACCESS ...

Canalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for ...

“Bend's proven expertise in formulation and manufacturing complements our innovation and understanding of how to reduce toxicity and improve efficacy of lenalidomide and we're eager to partner with ...

A traffic stop in Clark County recently resulted in the seizure of 13 boxes of Promethazine. The Arkansas State Police said ...

VANCOUVER, BC / ACCESS Newswire / June 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:BNXTF)(FSE:BXT), is pleased to announce the launch of a feasibility study for the ...

XYZ Media, a leading media company that bridges educational pursuits with technological innovation, is proud to announce the ...

Partner: Aura Biosciences Title: Bel-sar - a New Treatment Paradigm in Choroidal Melanoma: Update on the Global Phase 3 CoMpass Trial Presented by: Jennifer Lim, MD, Professor of Ophthalmology, ...

LONDON, GREATER LONDON, UNITED KINGDOM, June 13, 2025 /EINPresswire.com/ -- There has been a significant expansion in the cyclosporine drugs market size in recent years. The detailed analysis suggests ...

A weekly oral risperidone capsule has shown promising results in schizophrenia treatment, maintaining stable drug levels, ...

Shares of Eton Pharmaceuticals Inc (NASDAQ:ETON) saw a 3.3% boost in premarket trading after the company announced U.S. Food and Drug Administration (FDA) approval of KHINDIVI™ (hydrocortisone) Oral ...